Log in
Sign up
free
Home
Sectors
Earnings
IPOs
Splits
Example searches
AAPL 10-K FY2019
Visa 10-Q
shopify
renewables AND wind 8-K 6-K NOT TAC
cryptocurrency OR "blockchain technology" OR bitcoin 2018-2021
ATRS
Dashboard
ATRS
Financials
Financials
Data Charts
Data
Institutional Ownership Data
Ownership
Insider Trades
Insider
Short Interest
Shorts
ESG
ESG
All Filings
Filings
Patents
8-K Filing
8-K
ATRS
Antares Pharma
8-K
2021
Antares Pharma Announces Full-year 2021 Revenue Guidance of $175-200 Million
11 Jan 21
Files
SEC
8-K
Current report
99.1
EX-99.1 Press Release
99.2
EX-99.2 Investor Presentation
Download Excel data file
View Excel data file
Content Analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
ATRS 8-K Filings
11 Jan 21
Antares Pharma Announces Full-year 2021 Revenue Guidance of $175-200 Million
12 Nov 20
Regulation FD Disclosure
5 Nov 20
Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results
1 Oct 20
Other Events
Filing View
Default size
S
M
L
Default font
Times
Arial
Search this filing
Search
All
Tables only
Footnotes only
Pre-defined:
Material
ESG
Footnotes
Table of Contents
Get all this for free
Email alerts for new filings that match keywords or companies
Plot, compare & download financial data
10-K & 10-Q redlined comparisons
Advanced filing search & analysis
Sentiment analysis for financial filings
Favorites, search history, and more…
Sign up for free now
More benefits
Top
ATRS